Somatoform disorders. The first part: integrative model f pathology
Abstract
The problem of somatoform disorders (SFD) was regarded in accordance with the biopsychosocial concept of mental pathology. It was described the role of biological, social and psychological factors in the development of SFD. The representation of the interaction of these phenomena in the process of occurrence and further development of the SFD was gave. Predisposing factors (genetic predisposition, disturbance of neurotransmitters’ metabolism, misbalance of immune and endocrine systems, as well as personality’s typology), perpetuating factors (cognitive features, low opportunity of coping, abnormal behavior patterns, features of emotional response), precipitating factors (stress, social influence) were emphasized. Proposed multifactorial model can be used to improve care for patients who suffer from SFD, especially useful can be development of a cognitive-behavioral intervention.
About the Authors
A. A. Pribytkov
Penza institution of advanced medical studies
Russian Federation
Russian Federation
A. N. Erichev
St. Petersburg Psychoneurological Research Institute named after V.M. Behterev
Russian Federation
Russian Federation
References
1. Боброва М.А. Эмоциональные, когнитивные и личностные нарушения при соматоформных расстройствах (типология, терапия и прогноз) // Автореф. дисс. канд. - М. - 2012. - 23 с.
2. Десятников В.Ф., Сорокина Т.Т. Скрытая депрессия в практике врачей // Минск: Выш. Школа. - 1981. - 240 с.
3. Коцюбинский А.П. Аутохтонные непсихотические расстройства // СПб.: Спец-Лит. - 2015. - 495 с.
4. Краснов В.Н. Диагноз и классификация психических расстройств в русскоязычной психиатрии: раздел расстройств аффективного спектра // Социальная и клиническая психиатрия. - 2010. - Т. 20, № 4. - С. 58-63.
5. Овсянников С.А., Цыганков Б.Д. Пограничная психиатрия и соматическая патология: Клинико-практическое руководство // М.: Триада-Фарм. - 2001. - 100 с.
6. Плетнев Д.Д. К вопросу о соматической циклотимии // Русская клиника. - 1927. - Т. 7, № 36. - С. 496-500.
7. Прибытков А.А., Юркова И.О., Баженова Ю.Б. Особенности личности и механизмов психологических защит у больных соматоформными расстройствами // Актуальные вопросы геронтологии и гериатрии в психиатрии: сборник статей. - Пенза. - 2015. - С. 96-99.
8. Рассказова Е.И. Роль нарушений когнитивной и эмоциональной регуляции в возникновении соматических симптомов // Вопросы психологии. - 2013. - № 6. - С. 87-97.
9. Семичов С.Б. Предболезненные психические расстройства // Л.: Медицина. - 1987. - 182 с.
10. Собенников В.С. Соматизация и соматоформные расстройства // Иркутск. - 2014. - С. 132-141.
11. Холмогорова А.Б., Гаранян Н.Г. Соматизация: современные трактовки, психологические модели и методы психотерапии. Часть 1 // Современная терапия психических расстройств. - 2008. - № 2. - С. 31-35
12. Чижова А.И. Клинико-психологические аспекты патогенеза соматоформных невротических расстройств // Вестник Южно-Уральского государственного университета. Серия ««Психология». - 2012. - Вып.16, № 6. - С. 138-144.
13. Apfel R.J., Sifneos P.E. Alexithymia: concept and measurement // Psychother. Psychosom. -1979. - Vol. 32, № 1-4. - P. 180-190.
14. Bailer J., Witthöft M., Bayerl C., Rist F. Trauma experience in individuals with idiopathic environmental intolerance and individuals with somatoform disorders // J. Psychosom. Res. - 2007. - Vol. 63, № 6. - P. 657-661.
15. Barsky A.J., Orav E.J., Bates D.W. Somatization increases medical utilization and costs independent of psychiatric and medical comorbidity // Arch. Gen. Psychiatry. - 2005. - Vol. 62. - P. 903-910.
16. Barsky A.J., Wyshak G. Hypochondriasis and somatosensory amplification // Br. J. Psychiatry. -1990. - Vol. 157. - P. 404-409.
17. Beck J.E. A developmental perspective on functional somatic symptoms // J. Pediatr. Psychol. - 2008. - Vol. 33, № 5. - P. 547-562.
18. Bi X., Moos R.H., Timko C., Cronkite R.C. Family conflict and somatic symptoms over 10 years: a growth mixture model analysis // J. Psychosom. Res. - 2015. - Vol. 78, № 5. - P. 459-465.
19. Creed F., Guthrie E., Fink P. et al. Is there a better term than “Medically unexplained symptoms”? // J. Psychosom. Res. - 2010. - Vol. 68. - P. 5-8.
20. Creed F. Should general psychiatry ignore somatization and hypochondriasis? // World Psychiatry. - 2006. - Vol. 5. - P. 146-150.
21. de Waal M.W., Arnold I.A., Eekhof J.A. et al. Follow-up study on health care use of patients with somatoform, anxiety and depressive disorders in primary care // BMC Fam. Pract. - 2008. - Vol. 9. - P. 5.
22. Dirkzwager A.J., Verhaak P.F. Patients with persistent medically unexplained symptoms in general practice: characteristics and quality of care // BMC Fam. Pract. - 2007. - Vol. 8. - P. 33.
23. Engel G.L. The need for a new medical model: a challenge for biomedicine // Science. - 1977. - Vol. 196, № 4286. - P. 129-136.
24. Garcia Nunez D., Rufer M., Leenen K. et al. Quality of life and alexithymia in somatoform pain disorder // Schmerz. - 2010. - Vol. 24, № 1. - P. 62-68.
25. Garcia-Campayo J., Alda M., Sobradiel N. et al. Personality disorders in somatization disorder patients: a controlled study in Spain // J. Psychosom. Res. - 2007. - Vol. 62, № 6. - P. 675-680.
26. Gili M., Luciano J.V., Serrano M.J. et al. Mental disorders among frequent attenders in primary care: a comparison with routine attenders // J. Nerv. Ment. Dis. - 2011. - Vol. 199, № 10. - P. 744-749.
27. Groben S., Hausteiner C. Somatoform disorders and causal attributions in patients with suspected allergies: Do somatic causal attributions matter? // J. Psychosom. Res. - 2011. - Vol. 70, № 3. - P. 229-238.
28. Haftgoli N., Favrat B., Verdon F. et al. Patients presenting with somatic complaints in general practice: depression, anxiety and somatoform disorders are frequent and associated with psychosocial stressors // BMC Fam. Pract. 2010. - Vol. 11. - P. 67.
29. Heim C., Ehlert U., Hellhammer D.H. The potential role of hypocortisolism in the pathophysiology of stress-related bodily disorders // Psychoneuroendocrinology. - 2000. - Vol. 25, № 1. - P. 1-35.
30. Hennings A., Zill P., Rief W. Serotonin transporter gene promoter polymorphism and somatoform symptoms // J. Clin. Psychiatry. - 2009. - Vol. 70, № 11. - P. 1536-1539.
31. Henningsen P., Jakobsen T., Schiltenwolf M., Weiss M.G. Somatization revisited: diagnosis and perceived causes of common mental disorders // J. Nerv. Ment. Dis. - 2005. - Vol. 193, № 2. - P. 85-92.
32. Henningsen P., Zipfel S., Herzog W. Management of functional somatic syndromes // Lancet. - 2007. - Vol. 369. - P. 946-955.
33. Hiller W., Cebulla M., Korn H.J. et al. Causal symptom attributions in somatoform disorder and chronic pain // J. Psychosom. Res. - 2010. - Vol. 68, № 1. - P. 9-19.
34. Holliday K.L., Macfarlane G.J., Nicholl B.I. et al. Genetic variation in neuroendocrine genes associates with somatic symptoms in the general population: results from the EPIFUND study // J. Psychosom. Res. - 2010. - Vol. 68, № 5. - P. 469-474.
35. Jackson J.L., Passamonti M. The outcomes among patients presenting in primary care with a physical symptom at 5 years // J. Gen. Intern. Med. - 2005. - Vol. 20, № 11. - P. 1032-1037.
36. Kato K., Sullivan P.F., Pedersen N.L. Latent class analysis of functional somatic symptoms in a population-based sample of twins // J. Psychosom. Res. - 2010. - Vol. 68, № 5. - P. 447-453.
37. Kostev K., Rex J., Waehlert L. et al. Risk of psychiatric and neurological diseases in patients with workplace mobbing experience in Germany: a retrospective database analysis // Ger. Med. Sci. - 2014. - Vol. 12. - Doc10.
38. Krautwurst S., Gerlach A.L., Gomille L. et al. Health anxiety - an indicator of higher interoceptive sensitivity? // J. Behav. Ther. Exp. Psychiatry. - 2014. - Vol. 45, № 2. - P. 303-309.
39. Lacourt T., Houtveen J., van Doornen L. «Functional somatic syndromes, one or many?» An answer by cluster analysis // J. Psychosom. Res. - 2013. - Vol. 74, № 1. - P. 6-11.
40. Lembo A.J., Zaman M., Krueger R.F. et al. Psychiatric disorder, irritable bowel syndrome, and extraintestinal symptoms in a population-based sample of twins // Am. J. Gastroenterol. - 2009. - Vol. 104, № 3. - P. 686-694.
41. Lenze E.J., Miller A.R., Munir Z.B. et al. Psychiatric symptoms endorsed by somatization disorder patients in a psychiatric clinic // Ann. Clin. Psychiatry. -1999. - Vol. 11, № 2. - P. 73-79.
42. Lind A.B., Delmar C., Nielsen K. Struggling in an emotional avoidance culture: a qualitative study of stress as a predisposing factor for somatoform disorders // J. Psychosom. Res. - 2014. - Vol. 76, № 2. - P. 94-98.
43. Löwe B., Spitzer R.L., Williams J.B. et al. Depression, anxiety and somatization in primary care: syndrome overlap and functional impairment // Gen. Hosp. Psychiatry. - 2008. - Vol. 30, № 3. - P. 191-199.
44. Martin A., Rief W. Relevance of cognitive and behavioral factors in medically unexplained syndromes and somatoform disorders // Psychiatr. Clin. North Am. - 2011. - Vol. 34, № 3. - P. 565-578.
45. Mattila A.K., Kronholm E., Jula A. et al. Alexithymia and somatization in general population // Psychosom. Med. - 2008. - Vol. 70, № 6. - P. 716-722.
46. McKenzie M., Clarke D.M., McKenzie D.P., Smith G.C. Which factors predict the persistence of DSM- IV depression, anxiety, and somatoform disorders in the medically ill three months post hospital discharge? // J. Psychosom. Res. - 2010. - Vol. 68, № 1. - P. 21-28.
47. Mewes R., Rief W., Brähler E. et al. Lower decision threshold for doctor visits as a predictor of health care use in somatoform disorders and in the general population // Gen. Hosp. Psychiatry. - 2008. - Vol. 30, № 4. - P. 349-355.
48. Nimnuan C., Hotopf M., Wessely S. Medically unexplained symptoms: an epidemiological study in seven specialities // J. Psychosom. Res. - 2001. - Vol. 51. - P. 361-367.
49. North C.S. The Classification of Hysteria and Related Disorders: Historical and Phenomenological Considerations // Behav. Sci. (Basel). - 2015. - Vol. 5, № 4. - P. 496-517.
50. Offenbaecher M., Bondy B., de Jonge S. et al. Possible association of fibromyalgia with a polymorphism in the serotonin transporter gene regulatory region // Arthritis Rheum. - 1999. - Vol. 42, № 11. - P. 2482-2488.
51. Pukhalsky A.L., Shmarina G.V., Alioshkin V.A., Sabelnikov A. HPA axis exhaustion and regulatory T cell accumulation in patients with a functional somatic syndrome: recent view on the problem of Gulf War veterans // J. Neuroimmunol. - 2008. - Vol. 196, № 1-2. - P. 133-138.
52. Rief W., Mewes R., Martin A. et al. Are psychological features useful in classifying patients with somatic symptoms? // Psychosom. Med. - 2010. - Vol. 72, № 7. - P. 648-655.
53. Rief W., Nanke A., Emmerich J. et al. Causal illness attributions in somatoform disorders: associations with comorbidity and illness behavior // J. Psychosom. Res. - 2004. - Vol. 57, № 4. - P. 367-371.
54. Rief W., Pilger F., Ihle D. et al. Immunological differences between patients with major depression and somatization syndrome // Psychiatry Res. - 2001. - Vol. 105, № 3. - P. 165-174.
55. Rief W., Pilger F., Ihle D. et al. Psychobiological aspects of somatoform disorders: contributions of monoaminergic transmitter systems // Neuropsychobiology - 2004. - Vol. 49. - P. 24-29.
56. Rohlof H.G., Knipscheer J.W., Kleber R.J. Somatization in refugees: a review // Soc. Psychiatry Psychiatr. Epidemiol. - 2014. - Vol. 49, № 11. - P. 1793-1804.
57. Schulte I.E., Petermann F. Familial risk factors for the development of somatoform symptoms and disorders in children and adolescents: a systematic review // Child Psychiatry Hum. Dev. - 2011. - Vol. 42, № 5. - P. 569-583.
58. Simon G.E. et al. Are somatoform disorders a distinct category? // In: Maj M., Akiskal H.S., Mezzich J.E. et al., editors. Somatoform disorders. - Chichester: Wiley. - 2005. - P. 29-31.
59. Tanriverdi F., Karaca Z., Unluhizarci K., Kelestimur F. The hypothalamo-pituitary-adrenal axis in chronic fatigue syndrome and fibromyalgia syndrome // Stress. - 2007. - Vol. 10, № 1. - P. 13-25.
60. Thomson K., Randall E., Ibeziako P., Bujoreanu I.S. Somatoform disorders and trauma in medically-admitted children, adolescents, and young adults: prevalence rates and psychosocial characteristics // Psychosomatics. - 2014. - Vol. 55, № 6. - P. 630-639.
61. Tomenson B., McBeth J., Chew-Graham C.A. et al. Somatization and health anxiety as predictors of health care use // Psychosom. Med. - 2012. - Vol. 74, № 6. - P. 656-664.
62. Tominaga T., Choi H., Nagoshi Y. et al. Relationship between alexithymia and coping strategies in patients with somatoform disorder // Neuropsychiatr. Dis. Treat. - 2014. - Vol. 10. - P. 55-62.
63. van der Boom K.J., Houtveen J.H. Psychiatric comorbidity in patients in tertiary care suffering from severe somatoform disorders // Tijdschr. Psychiatr. - 2014. - Vol. 56, № 11. - P. 743-747.
64. van Gils A., Burton C., Bos E.H. et al. Individual variation in temporal relationships between stress and functional somatic symptoms // J. Psychosom. Res. - 2014. - Vol. 77, № 1. - P. 34-39.
65. Verhaak P.F., Meijer S.A., Visser A.P., Wolters G. Persistent presentation of medically unexplained symptoms in general practice // Fam. Pract. - 2006. - Vol. 23, № 4. - P. 414-420.
66. White K.S., McDonnell C.J., Gervino E.V. Alexithymia and anxiety sensitivity in patients with non-cardiac chest pain // J. Behav. Ther. Exp. Psychiatry. - 2011. - Vol. 42, № 4. - P. 432-439.
67. Wilhelmsen I. Biological sensitisation and psychological amplification: gateways to subjective health complaints and somatoform disorders // Psychoneuroendocrinology. - 2005. - Vol. 30, № 10. - P. 990-995.
68. Wittchen H.U., Jacobi F., Rehm J. et al.The size and burden of mental disorders and other disorders of the brain in Europe 2010 // Eur. Neuropsychopharmacol. - 2011. - Vol. 21, № 9. - P. 655-679.
69. Woolfolk R.L., Allen L.A. Treating somatization: a cognitive-behavioral approach // New York, Guilford Press. - 2006. - 226 p
Review
For citations:
Pribytkov A.A., Erichev A.N. Somatoform disorders. The first part: integrative model f pathology. V.M. BEKHTEREV REVIEW OF PSYCHIATRY AND MEDICAL PSYCHOLOGY. 2017;(1):3-10. (In Russ.)
Views:
1076
Email this article 